Green Thumb Industries (GTBIF) Cash from Investing Activities (2019 - 2026)
Green Thumb Industries (GTBIF) reported Cash from Investing Activities of -$20.6 million for Q1 2026, up 32.69% on a YoY basis from -$15.5 million in Q1 2025, and down 7.44% quarter-over-quarter from -$19.2 million in Q4 2025.
Green Thumb Industries (GTBIF) Cash from Investing Activities (2019 - 2026) Analysis & Trends
Green Thumb Industries has reported Cash from Investing Activities for 8 years, with the latest figure at -$20.6 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities rose 32.69% year-over-year to -$20.6 million; the trailing twelve-month figure through Mar 2026 stood at -$120.4 million (down 9.61% YoY), and the FY2025 full-year result was -$130.4 million, down 45.63% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$20.6 million, down from -$19.2 million in the prior quarter.
- The five-year high for Cash from Investing Activities was -$10.3 million in Q1 2024, with the low at -$100.4 million in Q1 2022.
- Historically, Cash from Investing Activities has averaged -$40.5 million across 5 years, with a median of -$36.1 million in 2024.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities tumbled 1286.56% — and 2024, when it surged 84.65%.
- Green Thumb Industries' Cash from Investing Activities stood at -$58.8 million in 2022, then soared by 31.16% to -$40.5 million in 2023, then gained by 10.78% to -$36.1 million in 2024, then soared by 46.95% to -$19.2 million in 2025, then declined by 7.44% to -$20.6 million in 2026.
- The last three Cash from Investing Activities figures came in at -$20.6 million (Q1 2026), -$19.2 million (Q4 2025), and -$13.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 229.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | -87.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 743.70 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | -506.20 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | -60.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -2.08 Bn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 25.99 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -15.45 Mn |
| 10 | Green Thumb Industries | - | - | 143.65 Mn | -20.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.58 Mn |
| Mar 31, 2026 | -20.58 Mn |
| Dec 31, 2025 | -19.15 Mn |
| Dec 31, 2025 | -19.15 Mn |
| Sep 30, 2025 | -13.00 Mn |
| Sep 30, 2025 | -13.00 Mn |
| Jun 30, 2025 | -67.67 Mn |
| Jun 30, 2025 | -67.67 Mn |
| Mar 31, 2025 | -30.57 Mn |
| Mar 31, 2025 | -30.57 Mn |
| Dec 31, 2024 | -36.10 Mn |
| Dec 31, 2024 | -36.10 Mn |
| Sep 30, 2024 | -19.11 Mn |
| Sep 30, 2024 | -19.11 Mn |
| Jun 30, 2024 | -24.06 Mn |
| Jun 30, 2024 | -24.06 Mn |
| Mar 31, 2024 | -10.27 Mn |
| Mar 31, 2024 | -10.27 Mn |
| Dec 31, 2023 | -40.46 Mn |
| Dec 31, 2023 | -40.46 Mn |